|   
Follow us
◦ Pfizer
Two drugs, two strategies, one industry in the middle of rewiring its path to success - China Biopharma News
Biopharma

Two drugs, two strategies, one industry in the middle of rewiring its path to success

On May 20 Pfizer announced a US 6.05 billion licensing agreement with 3SBio a Chinese pharmaceutical company headquartered in the northeastern city of Shenyang for its in house developed...
Daily Buzz: 21 May 2025 - China Economy News
Economy

Daily Buzz: 21 May 2025

3SBio Pfizer agreement
A cure worse than the disease? Trump's pharma tariffs portend paralysis instead of progress - China Biopharma News
Biopharma

A cure worse than the disease? Trump's pharma tariffs portend paralysis instead of progress

Pfizer Chief Executive Albert Bourla is equally worried. While agreeing on the need for a more secure drug supply he doubts that tariffs will help. The New York based company said...
Chinese biotech companies hit inflection point on way to world prominence - China Biopharma News
Biopharma

Chinese biotech companies hit inflection point on way to world prominence

1 percent to 5.72 billion yuan US 782.7 million . While that may still fall short of leading multinationals like Pfizer Novartis Amgen and Gilead Henlius and other China biotech...
China biotech becomes powerful player in research for new drug therapies - China Opinion
Opinion

China biotech becomes powerful player in research for new drug therapies

Interestingly the market is now debating whether a new trial drug collaboration partnership between Akeso and US based pharma giant Pfizer announced coincidentally with the CNN report...
Global powerhouses awarded for their role in Jing'an's success - China Economy News
Economy

Global powerhouses awarded for their role in Jing'an's success

Other notable awardees included global giants SAP KPMG Gucci TUV Rheinland and Pfizer alongside prominent domestic players Guotai Junan Securities Ping An Asset Management and...
Expo promotes family-friendly products and services - Shanghai Metro News
Metro

Expo promotes family-friendly products and services

At the CIIE Dr Yao Zhirong from Xinhua Hospital reported the development of a research collaborated with Pfizer to generate valuable data that informs global clinical practices and...
Once fatal cancers now manageable chronic diseases - Shanghai Metro News
Metro

Once fatal cancers now manageable chronic diseases

During the CIIE the China International Exchange and Promotive Association for Medical and Health Care signed cooperation agreement with Pfizer to push the clinical recovery awareness...
Pharma firms showcase innovative treatment for major diseases at CIIE - Shanghai Metro News
Metro

Pharma firms showcase innovative treatment for major diseases at CIIE

On the first day of the CIIE Pfizer announced that China has approved its innovative prostate cancer treatment Talazoparib.
Novartis China president promoted to CCO, international - China Company News
Company

Novartis China president promoted to CCO, international

Prior to joining Novartis in 2011 she held management roles for multinational pharmaceutical companies including AstraZeneca and Pfizer in different locations.